The companies did not disclose the financial details of the agreement, but said terms were based on the volume of doses and the timing of the delivery. The United States has signed a similar deal with Pfizer and BioNtech for 100 million doses for nearly $2 billion, which amounts to a $39 price tag for what is likely to be a two dose treatment course.
Share this
